A groundbreaking study published in Cardiovascular Research unveils AB-Biotics’ AB-Life probiotic strains’ profound cardiometabolic benefits in combating atherosclerotic cardiovascular diseases (ACVDs). Led by AB-Biotics, the research demonstrates how AB-Life, containing Lactiplantibacillus plantarum strains, reduces LDL particle sizes and apolipoproteins, pivotal biomarkers in atherosclerosis development. The study highlights the probiotics’ role in bile acid metabolism, lowering LDL-C and ApoB protein levels, while also improving gut microbiota composition and offering protection against dyslipidemia. This discovery underscores the potential of probiotics in enhancing cardiovascular health and prompts further investigation into their therapeutic applications.
Home » AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Cranberry Power for Muscle Performance
March 21, 2025
Anticancer role of Mango peel and seed kernel extracts
March 15, 2025
Creatine – Beyond Muscle Power
March 15, 2025
Mindrevive: A Sage-Rutin Nootropic for Cognitive Support
March 7, 2025
Fisetin – The Longevity Flavonoid
March 7, 2025
EpiCor postbiotic – Immune health in children
March 7, 2025